BERKELEY LIGHTS PRESS RELEASES See all the latest Berkeley Lights announcements, including new products, services and partnerships. NOVO NORDISK PURCHASES BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM FOR CELL LINE DEVELOPMENT AND ANTIBODY DISCOVERY Emeryville, Calif. - October 15, 2018 — READ > BERKELEY LIGHTS CLOSES $95 MILLION FUNDING ROUND TO EXPEDITE COMMERCIAL EXPANSION AND PLATFORM DEVELOPMENT FOR CELL THERAPY Emeryville, Calif. - October 15, 2018 — READ > BERKELEY LIGHTS APPOINTS DR. MICHEL SADELAIN TO STRATEGIC SCIENTIFIC ADVISORY BOARD Emeryville, Calif. - August 29, 2018 — READ > CATALENT BIOLOGICS ADOPTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM TO ACCELERATE CELL LINE DEVELOPMENT - July 10, 2018 — READ > BERKELEY LIGHTS AND CHEMPARTNER COLLABORATE ON ACCELERATING ANTIBODY DISCOVERY Emeryville, Calif. - June 27, 2018 — READ > BERKELEY LIGHTS AND TPG BIOLOGICS ENTER INTO A STRATEGIC COLLABORATION FOR CELL LINE DEVELOPMENT Emeryville, Calif. - May 23, 2018 — READ > BERKELEY LIGHTS’ ANNOUNCES NEW AGREEMENT WITH SANOFI FOR BEACON® OPTOFLUIDIC PLATFORM Emeryville, Calif. - April 19, 2018 — READ > MD ANDERSON AND BERKELEY LIGHTS LAUNCH OPTERA THERAPEUTICS TO ACCELERATE DEVELOPMENT OF CELL THERAPIES FOR CANCER Houston, TX and Emeryville, CA - March 07, 2018 — READ > SHIRE ADOPTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM TO SPEED CELL LINE DEVELOPMENT Emeryville, Calif. - January 30, 2018 — READ > ANOTHER LARGE PHARMA IMPLEMENTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM FOR ACCELERATING ANTIBODY DISCOVERY Emeryville, Calif. - January 16, 2018 — READ > Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Next page Next › Last page Last »
